You are here: Home » Reuters » News
Business Standard

Pfizer rolls back drug price hikes temporarily after talking with Trump

The Trump administration has not yet taken significant action to lower drug prices

Reuters  |  Washington/New York 

Pfizer Inc said on Tuesday it was deferring drug price increases for no more than six months after the company's chief executive officer had an extensive conversation with US President Donald Trump. The rollback came a day after Trump took aim at Pfizer and other US drugmakers for raising prices on some of their medicines, saying in a tweet that they "should be ashamed" and that his administration would respond. Pfizer on Tuesday said it would defer price increases that went into effect on July 1 until the end of the year or until the president's drug pricing ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, July 11 2018. 12:25 IST
RECOMMENDED FOR YOU